SCHEMBL5034181

SCHEMBL5034181

CC(C)C([Si](Cl)(Cl)Cl)[Si](Cl)(Cl)Cl

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL705202 0.67
SCHEMBL8406552 0.67
SCHEMBL7593959 0.67 ALDH1A1 (0.31) ALDH1A1TSHRHSD17B10
SCHEMBL126333 0.64
SCHEMBL133587 0.64 ALDH1A1 (0.33) ALDH1A1TSHR
SCHEMBL11775574 0.61
SCHEMBL20815922 0.61 ALDH1A1 (0.31) ALDH1A1TSHR
SCHEMBL27812179 0.61
SCHEMBL11741937 0.61
SCHEMBL3627035 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 WO disclosed